Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Pharmaceutical Research|July 10, 2015
Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)Manthena V Varma, Stefanus J Steyn, Charlotte Allerton, et al.Vaccine|March 13, 2024
UK healthcare professionals' attitudes towards the introduction of varicella vaccine into the routine childhood vaccination schedule and their preferences for administrationSusan M Sherman, Charlotte Allerton-Price, Nicola Lingley-Heath, et al.Drug Discovery Today|November 1, 2020
Reviving an R&D pipeline: a step change in the Phase II success rateShuang S Wu, Kathy Fernando, Charlotte Allerton, et al.Drug Discovery Today|May 20, 2021
Innovation in breakthrough drugs and vaccines: Development risk, patient impact, and valueAndrew E Prigodich, Shuntai Wang, Patrick Verhoest, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2024
Virologic Response and Safety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With COVID-19Mahta Mortezavi, Abigail Sloan, Ravi Shankar P Singh, et al.Journal of Medicinal Chemistry|November 10, 2007
Discovery of potent & selective inhibitors of activated thrombin-activatable fibrinolysis inhibitor for the treatment of thrombosisMark E Bunnage, Julian Blagg, John Steele, et al.Biorxiv : the Preprint Server for Biology|September 16, 2020
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19Britton Boras, Rhys M Jones, Brandon J Anson, et al.Nature Communications|October 19, 2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19Britton Boras, Rhys M Jones, Brandon J Anson, et al.Pageof 1